Investments
Jul. 13, 2010
Latham Advises Biotech in Financing
Mark Roeder and Alan Mendelson, partners in Menlo Park, advised iPierian Inc., a South San Francisco biopharmaceutical company, in its Series B financing round totalling $22 million.
Daily Journal Staff Writer
Menlo Park-based Latham & Watkins partners Mark Roeder and Alan Mendelson advised iPierian Inc., a South San Francisco-based biopharmaceutical company, in its Series B financing round totalling $22 million. Notably, Google Ventures was lead investor in the round. It was joined by Mitsubishi UFJ Capital and ATEL Ventures, as well as current investors Kleiner Perkins Caulfield & Myers, Highlan...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In